Showing results (11-20 of 301) with videos related to
Sort By:
Pageof 31
Journal of Cellular Biochemistry|February 3, 2007
Stromal biology of pancreatic cancerGerald C Chu, Alec C Kimmelman, Aram F Hezel, et al.Genes & Development|May 17, 2006
Genetics and biology of pancreatic ductal adenocarcinomaAram F Hezel, Alec C Kimmelman, Ben Z Stanger, et al.Cancer Research|January 4, 2008
LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesisSushma Gurumurthy, Aram F Hezel, Ergun Sahin, et al.International Journal of Radiation Oncology, Biology, Physics|December 17, 2011
Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlationAlan W Katz, Sheema Chawla, Zhenhong Qu, et al.BMC Gastroenterology|January 16, 2013
Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinomaGregory C Connolly, Saman Safadjou, Randeep Kashyap, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancerBrian M Wolpin, Aram F Hezel, Thomas Abrams, et al.Cancer Investigation|October 18, 2012
Diabetes mellitus is associated with the presence of metastatic spread at disease presentation in hepatocellular carcinomaGregory C Connolly, Saman Safadjou, Rui Chen, et al.Investigational New Drugs|July 30, 2011
A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancerJason E Faris, Jamie Arnott, Hui Zheng, et al.Gastrointestinal Cancer Research : GCR|February 28, 2012
Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapyBrian M Alexander, Carlos Fernandez-Del Castillo, David P Ryan, et al.The Oncologist|January 3, 2012
Panitumumab in patients with KRAS wild-type colorectal cancer after progression on cetuximabRaymond C Wadlow, Aram F Hezel, Thomas A Abrams, et al.Pageof 31